Almitas Capital LLC

Holdings History for AN2 Therapeutics, Inc. - Common Stock, par value $0.00001 per share (ANTX)

Symbol: ANTX on Nasdaq
Investment type: Equity / Common Stock, par value $0.00001 per share
Latest Disclosed Shares Owned: 2,975,164 shares
Security Ownership %: 5.4%

Shares, Excluding Options vs Price

Value, Excluding Options

Almitas Capital LLC ownership in AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX)

17 Feb 2026 - Almitas Capital LLC has filed an SCHEDULE 13G form with the Securities and Exchange Commission (SEC) disclosing ownership of 2,975,164 shares of AN2 Therapeutics, Inc. Common Stock, par value $0.00001 per share (ANTX). This represents 5.4% ownership of the company. In their previous filing dated 14 Nov 2025, Almitas Capital LLC had reported owning 1,428,323 shares, indicating an increase of +108%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Almitas Capital LLC	5.4%	+4%	$3,927,216	2,975,164	+1,546,841	+108%	$1.32	13G	31 Dec 2025	17 Feb 2026, 18:54
Almitas Capital LLC	5.2%		$1,813,970	1,428,323			$1.27	13G	30 Sep 2025	14 Nov 2025, 19:51

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.37%	+0.01%	$1,686,207	1,479,129	+50,806	+3.6%	$1.14	Q4 2025
30 Sep 2025	0.42%	0%	$1,813,970	1,428,323	0		$1.27	Q3 2025
30 Jun 2025	0.38%	+0.03%	$1,514,022	1,428,323	+115,212	+8.8%	$1.06	Q2 2025
31 Mar 2025	0.59%	0%	$1,785,831	1,313,111	0		$1.36	Q1 2025
31 Dec 2024	0.4%	+0.4%	$1,812,093	1,313,111	+1,313,111	NEW	$1.38	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.